Stocks · Healthcare · Medical - Devices
Electromed, Inc. ELMD
$28.10 -1.40% Close, Oct 2, 2026 · AMEX · Market cap $232.7M
High qualityInexpensive vs sectorLow risk
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- At 21.5× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- Earnings beat analyst estimates in each of the last 11 quarters (average surprise over the last four: +22.5%).
- Diluted EPS over the last four quarters was $1.31, up 56.0% year over year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 39%
- EPS growth (TTM, YoY)Top 25%
- FCF growth (TTM, YoY)Bottom 28%
- Revenue growth, 3-year CAGRTop 39%
- Revenue growth accelerationBottom 37%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 5%
- Gross marginTop 32%
- Operating marginTop 14%
- Cash conversion (OCF / net income)Bottom 20%
- Accruals (lower is better)Bottom 13%
- Net debt / EBITDA (lower is better)Top 17%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 11%
- Free-cash-flow yieldTop 22%
- EBITDA / enterprise valueTop 16%
- Sales / enterprise valueTop 38%
- P/E vs own 5-year history (lower is better)Top 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 46%
- 6-month returnTop 38%
- 1-year return vs S&P 500Top 48%
- Distance from 52-week highBottom 40%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 21%
- Consecutive EPS beatsTop 5%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 46%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 47%
- Maximum drawdown, 3 yearsTop 22%
- Beta vs S&P 500 (lower is better)Top 32%
- Net debt / EBITDA (lower is better)Top 17%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 16.8% | 15.3% | ↓ |
| EPS growth (YoY) | 48.1% | 56.0% | ↑ |
| Gross margin | 78.1% | 78.5% | ↑ |
| Operating margin | 15.4% | 18.8% | ↑ |
| FCF margin | 17.5% | 12.5% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 15.3% | 16.8% | ↓ | Top 39% |
| EPS growth (TTM, YoY) | 56.0% | 48.1% | ↑ | Top 25% |
| Gross margin | 78.5% | 78.1% | ↑ | Top 32% |
| Operating margin | 18.8% | 15.4% | ↑ | Top 14% |
| Net margin | 15.3% | 11.8% | ↑ | — |
| Free-cash-flow margin | 12.5% | 17.5% | ↓ | — |
| Return on invested capital | 20.2% | — | Top 5% | |
| Revenue growth, 3-year CAGR | 15.4% | — | Top 39% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 0.86×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 2.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +9.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -1.33×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 1.34%
- Shareholder yield
- 1.34%
- Share count change, 1 year
- -0.3%
- Share count change, 3-year CAGR
- -0.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 25, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 11
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +22.5%
- Average 2-day reaction, last 8
- +0.7%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $48.50
- Target vs current price
- +72.6%
- Analysts with a rating
- 5
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 25, 2026 | +23.1% | -2.4% | -30.6% | -31.6% | — |
| May 12, 2026 | +34.6% | +4.9% | +47.5% | +40.0% | +62.1% |
| Feb 10, 2026 | +18.5% | +1.6% | -8.2% | -14.1% | -6.0% |
| Nov 12, 2025 | +13.6% | +1.1% | -2.3% | +16.1% | +10.0% |
| Aug 26, 2025 | +13.6% | +2.3% | +18.6% | +18.2% | +21.4% |
| May 13, 2025 | +5.0% | +1.7% | -2.0% | -11.2% | -16.9% |
| Feb 11, 2025 | +22.2% | -2.5% | -1.4% | -16.0% | -26.6% |
| Nov 12, 2024 | +433.3% | -1.5% | +4.6% | +8.4% | +11.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 25, 2026 | $0.39 | $0.32 | +23.1% | $19.4M |
| May 12, 2026 | $0.35 | $0.26 | +34.6% | $18.6M |
| Feb 10, 2026 | $0.32 | $0.27 | +18.5% | $18.9M |
| Nov 12, 2025 | $0.25 | $0.22 | +13.6% | $16.9M |
| Aug 26, 2025 | $0.25 | $0.22 | +13.6% | $17.4M |
| May 13, 2025 | $0.21 | $0.20 | +5.0% | $15.7M |
| Feb 11, 2025 | $0.22 | $0.18 | +22.2% | $16.3M |
| Nov 12, 2024 | $0.16 | $0.03 | +433.3% | $14.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 21.5× | 35.2× | 0th | Top 11% |
| P/E (forward) | 19.3× | — | — | — |
| EV / EBITDA | 13.9× | — | — | Top 16% |
| EV / Sales | 2.88× | — | — | Top 38% |
| Free-cash-flow yield | 3.98% | — | — | Top 22% |
| Earnings yield | 4.66% | — | — | Top 11% |
P/E over the past five years
Range 22.6× – 60.1× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +14.5%
- Earnings per share growth (TTM)
- +56.0%
- Change in P/E multiple
- +22.1%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -15.6%
- 200-day average slope (20 days)
- +0.0%
- Distance from 50-day average
- -16.9%
- Distance from 200-day average
- -10.5%
- RSI (14)
- 38.8
- Relative volume
- 0.86×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 54.3%
- Volatility vs own 5-year history
- 79th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.83
- Correlation with S&P 500
- 0.25
- Current drawdown from 1-year high
- -39.3%
- Maximum drawdown, 3 years
- -48.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 29, 2025 | Jul 21, 2025 | -48.9% | 118 days | 206 days (May 14, 2026) |
| Jul 6, 2026 | Sep 16, 2026 | -43.5% | 51 days | Not yet recovered |
| Sep 3, 2021 | Jul 20, 2022 | -35.9% | 219 days | 397 days (Feb 16, 2024) |
| Feb 10, 2021 | May 13, 2021 | -25.1% | 64 days | 50 days (Jul 26, 2021) |
| May 3, 2024 | Jul 2, 2024 | -24.3% | 40 days | 53 days (Sep 17, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $232.7M
- P/E (TTM)
- 21.5
- EPS, diluted (TTM)
- $1.31
- Revenue (TTM)
- $73.8M
- 52-week range
- $23.01 – $47.40
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $41.7M | $48.1M | $54.7M | $64.0M | $73.8M |
| Gross profit | $31.4M | $36.5M | $41.7M | $50.0M | $57.9M |
| Operating income | $3.0M | $4.0M | $6.6M | $9.9M | $13.9M |
| Net income | $2.3M | $3.2M | $5.2M | $7.5M | $11.3M |
| EPS (diluted) | $0.26 | $0.36 | $0.58 | $0.86 | $1.30 |
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.7M | $16.3M | $15.7M | $17.4M | $16.9M | $18.9M | $18.6M | $19.4M |
| Net income | $1.5M | $2.0M | $1.9M | $2.2M | $2.1M | $2.8M | $3.0M | $3.4M |
| EPS (diluted) | $0.16 | $0.22 | $0.21 | $0.25 | $0.25 | $0.32 | $0.35 | $0.39 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | -$686,000 | $1.3M | $9.1M | $11.4M | $9.7M |
| Capital expenditure | -$1.5M | -$1.7M | -$395,000 | -$306,000 | -$1.3M |
| Free cash flow | -$2.2M | -$401,000 | $8.7M | $11.1M | $8.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1.4M | -$153,000 | -$275,000 | -$10.0M | -$3.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $20.4M
- Total assets
- $66.3M
- Total liabilities
- $12.3M
- Total debt
- $133,000
- Net debt
- -$20.3M
- Shareholders’ equity
- $54.0M
As of Jun 30, 2026 (filed Aug 25, 2026).
Short interest
- Shares sold short
- 206,831
- Days to cover
- 1.98
- Change vs previous report
- +13.0%
FINRA short interest, settlement date Sep 15, 2026.